Astrocytes are ubiquitous in the central nervous system (CNS). These cells possess thousands of individual processes, which extend out into the neuropil, interacting with neurons, other glia and blood vessels. Paralleling the wide diversity of their interactions, astrocytes have been reported to play key roles in supporting CNS structure, metabolism, blood-brain-barrier formation and control of vascular blood flow, axon guidance, synapse formation and modulation of synaptic transmission. Traditionally, astrocytes have been studied as a homogenous group of cells. However, recent studies have uncovered a surprising degree of heterogeneity in their development and function, in both the healthy and diseased brain. A better understanding of astrocyte heterogeneity is urgently needed to understand normal brain function, as well as the role of astrocytes in response to injury and disease.
Dynamic contacts are formed between endoplasmic reticulum (ER) and mitochondria that enable the exchange of calcium and phospholipids. Disturbed contacts between ER and mitochondria impair mitochondrial dynamics and are a molecular hallmark of Parkinson’s disease, which is also characterized by impaired complex I activity and dopaminergic neuron degeneration. Here, we analyzed the role of cysteine-rich with EGF-like domain (Creld), a poorly characterized risk gene for Parkinson’s disease, in the regulation of mitochondrial dynamics and function. We found that loss of Creld leads to mitochondrial hyperfusion and reduced ROS signaling in Drosophila melanogaster , Xenopus tropicalis , and human cells. Creld fly mutants show differences in ER-mitochondria contacts and reduced respiratory complex I activity. The resulting low–hydrogen peroxide levels are linked to disturbed neuronal activity and lead to impaired locomotion, but not neurodegeneration, in Creld mutants. We conclude that Creld regulates ER-mitochondria communication and thereby hydrogen peroxide formation, which is required for normal neuron function.
Currently there is no available therapy for efficient recovery from spinal cord injury (SCI), resulting in a permanent paralysis beneath the injury site. Mammals exhibit a very limited regenerative capacity; nevertheless, non-mammals like amphibian and teleost fish are capable of regeneration after severe SCI. This chapter focuses on Xenopus laevis as a model organism to study spinal cord regeneration. The advantages over other models, description of injury paradigms and methods that provide an opportunity to determine the necessary mechanisms for an effective regeneration process, and the mechanisms that fail in non-regenerative animals are presented. A brief summary from the first discoveries to the most recent about spinal cord regeneration, centering on the ones developed in Xenopus laevis, is also included. Particular attention is given to the differential response between regenerative and non-regenerative Xenopus laevis stages: (1) spinal cord cellular composition and their response to SCI, (2) presence of neural stem progenitor cells and their role in spinal cord regeneration, and (3) the differential biological processes involved in SCI and spinal cord regeneration and their correlation with other studies. Finally, a discussion about the pitfalls in this area of research and the future directions on spinal cord regeneration in Xenopus laevis is presented.